Active Government Funding Opportunities

Support high-impact investigator-initiated research addressing ovarian cancer through basic laboratory to translational studies. Projects must demonstrate strong scientific rationale with preliminary data and potential to advance patient care.

Support early-career ovarian cancer researchers through an intensive virtual academy offering mentoring, networking, and collaboration. The program develops productive scientists while advancing innovative ovarian cancer research in a structured peer-learning environment.

DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.

Support early-career clinical trialists developing new ovarian cancer treatments through intensive mentoring, networking, and conducting translational research and early-phase clinical trials.

This award funds clinical trials for new ovarian cancer treatments, from early proof-of-concept studies through large-scale efficacy trials. It supports evaluation of drugs, biologics, devices, and emerging technologies to improve patient outcomes.

DoD seeks breakthrough breast cancer research with high clinical potential, supporting projects from preclinical through early clinical stages. Applications must address priority research challenges and include consumer advocates as core team members.

Develop ALS therapeutics from preclinical validation through FDA IND-enabling studies. This award accelerates drug candidates toward clinical testing while requiring parallel development of mechanism-specific biomarkers for improved patient selection and trial design.

This DoD funding supports high-risk, hypothesis-driven research to discover new ALS drugs and therapies. Applications emphasizing novel approaches can succeed without preliminary data, enabling bold therapeutic innovation.

Develop and validate clinical biomarkers and outcome measures to improve ALS clinical trials, including digital health tools like wearables and AI-enabled monitoring. Projects should incorporate patient community input and may target specific ALS subtypes or therapeutic classes.

This DoD funding supports rapid clinical trials testing new ALS treatments, from phase 1 through small phase 2 studies. Focus areas include biomarker-driven interventions and improved clinical care approaches for managing the disease.

Support innovative, high-risk pancreatic cancer research ideas with potential for major breakthroughs. This award funds early-stage projects addressing key research priorities, including mentorship pathways for early-career investigators launching careers in pancreatic cancer science.

This award funds partnerships between clinicians and scientists to accelerate pancreatic cancer research from promising early-stage ideas toward clinical applications, including pilot trials and correlative studies.

This DoD program funds exploratory pancreatic cancer research with a patient-centered focus to develop innovative concepts and generate preliminary data for future clinical applications. Supported research should advance quality of life outcomes through robust studies that avoid preclinical animal work.

This DoD funding supports innovative research to transform Alzheimer's diagnosis and disease monitoring. Projects must demonstrate non-incremental solutions that overcome barriers to diagnosis and prognosis, with preliminary data and community collaboration required.

This DoD program funds clinical research and trials testing new care interventions for Alzheimer's disease and related dementia. Projects must demonstrate preliminary data, involve community collaboration, and address practical care solutions beyond drug testing.

Supports transformative research to identify and validate risk factors for Alzheimer's disease and develop prevention strategies. Projects must advance understanding of environmental, genetic, or lifestyle risks and propose actionable solutions to reduce AD/ADRD development.

DoD seeks translational arthritis research that bridges preclinical findings into clinical solutions for Service Members and Veterans. Projects must demonstrate high-impact, hypothesis-driven applied research with preliminary data and clear pathways to real-world medical applications.

This DoD clinical research award funds studies evaluating arthritis prevention, early diagnosis, and treatment approaches. Research generates evidence to optimize patient outcomes and inform clinical care through pilot studies or full-scale clinical trials with community collaboration.

ARORA develops advanced photonic technologies through cooperative partnerships, designing and testing prototype photonic systems for DoD applications and modernization efforts.

Golden Dome for America CSO for rapid technology development and deployment against advanced aerial threats including hypersonics and cruise missiles through agile contracting.

SAF/CDM Commercial Solutions Opening for innovative defense-related activities including Agile Refactoring and Integration. Two-step process with white papers and proposals.

TACTICAL Broad Agency Announcement from AFRL Directed Energy Directorate for five-year R&D in directed energy technologies with calls issued periodically for specific research efforts.

Air Force AFIMSC SPEED CSO with multiple closed/open areas including RF spectrum monitoring, BIM data, and data science capabilities for facilities and operations optimization.

Multi-Spectrum Defensive Electronic Warfare (MSDEW) ARA develops threat warning and countermeasures sensors/systems for contested environments through design, simulation, and testing.

Naval Air Warfare Center Broad Agency Announcement for R&D in manned/unmanned air platforms, advanced sensors (EO/IR/RF/acoustic), AI/ML processing, and naval air capabilities.